Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor.

Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor.

Item

http://www.wikidata.org/entity/Q34710444

Q34710444

about

The benefits and risks of testosterone replacement therapy: a review Androgen deprivation therapy and cardiovascular disease: what is the linking mechanism?Androgen receptor (AR) in cardiovascular diseases Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells Testosterone and vascular function in aging Estrogens in Male Physiology Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.Modulation of neointimal lesion formation by endogenous androgens is independent of vascular androgen receptor.Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies.Testosterone and cardiovascular risk.Connecting the Lines between Hypogonadism and Atherosclerosis.Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse Testosterone and the metabolic syndrome.Endogenous androgen deficiency enhances diet-induced hypercholesterolemia and atherosclerosis in low-density lipoprotein receptor-deficient mice.Testosterone and Cardiovascular Disease.Testosterone-induced effects on lipids and inflammation Testosterone and cardiovascular disease in men.Are declining testosterone levels a major risk factor for ill-health in aging men?Protective effects of physiological testosterone on advanced glycation end product‑induced injury in human endothelial cells.Update on the safety of testosterone therapy in cardiac disease.Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications.The relationship between testosterone deficiency and frailty in elderly men.Testosterone induces apoptosis in vascular smooth muscle cells via extrinsic apoptotic pathway with mitochondria-generated reactive oxygen species involvement.Effect of testosterone on the proliferation and collagen synthesis of cardiac fibroblasts induced by angiotensin II in neonatal rat.Low serum testosterone is associated with atherosclerosis in postmenopausal women undergoing hemodialysis.Metabolic and affective consequences of fatherhood in male California mice.Trials of testosterone replacement reporting cardiovascular adverse events.Effect of resveratrol and orchidectomy on the vasorelaxing influence of perivascular adipose tissue.Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.The androgen receptor drives the sex-specific expression of vascular cell adhesion molecule-1 in endothelial cells but not lipid metabolism genes in monocyte-derived macrophages.

P2860

Q24658011-3CFDF40C-B622-4434-B01E-8F1A752FDD79 Q26749088-6B1F08B4-AFFF-4790-BCE1-E98098641722 Q26771962-505E2AE2-0661-4EBD-99B8-6F3A8942CAAE Q27013914-62024E70-2E46-4610-B9AA-A7FBF886FD8D Q28383213-83F59DE8-3449-43A8-9FA9-4CD81421440B Q30090708-BF2CD5BC-313B-4FF9-A67A-975AF1EF5DF3 Q33668906-F283F117-EA81-4D7A-9681-545BDF69CD12 Q33890595-57EA17B9-3A07-4B22-A380-C38050EA4AEE Q34267991-2CCE1689-A41F-483A-BB2E-EA632425D95B Q34332054-79DC2F84-F7D1-4BE1-8A41-10E175211DB7 Q35810628-18248733-6A0B-4954-8541-3042975292EA Q36094424-BB3BD6B0-E2C1-4C10-BEE7-C964DD1BFE9A Q36327973-0F8E0371-0358-44A0-8EBB-D8B992E8C85E Q36353275-69424ECA-46C9-479C-AA9F-4FFA45621A78 Q36658618-AA655C29-266C-4AF8-9665-0AB62506D59A Q36771684-3E421F2D-70F0-47A6-8FE3-E68073368AA3 Q37037827-A5A08423-55A0-46D9-AB93-6C10BA1FAF81 Q37335851-04ECB4FF-2616-4BE8-B065-CA72C5C508A6 Q37722123-F2BF79E8-DA14-4E85-AF48-1AA2E05A1400 Q37854750-45E3B807-ADE6-4C12-A67A-FE25A606400B Q39395252-A724965C-369A-4438-A777-BEA482A04C96 Q40953550-ACFA02A3-832D-4681-A875-3BC244788827 Q42706285-EBAE0977-47B6-4322-B868-30ECD25AF33D Q42909153-4E9FE643-21C3-470C-91B8-815AD28C0CA5 Q43419904-533288C1-B237-48AD-BFDE-8E1953F2C3DE Q46001061-60F1DA01-9261-4F49-903B-71062177137A Q47571312-AA444B02-6A2D-4B16-8379-01ED4D9DC24D Q49150580-1AA42021-F02F-41A5-B695-4BA0679A0D4A Q50017410-74F5DD6B-C90E-4FB2-ACD3-D94A02951C19 Q51549993-0E322CF1-B0E9-4438-97BB-E898B8CF2806

P2860

Physiological testosterone replacement therapy attenuates fatty streak formation and improves high-density lipoprotein cholesterol in the Tfm mouse: an effect that is independent of the classic androgen receptor.

Item

http://www.wikidata.org/entity/Q34710444

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu